On November 21, the European Commission approved its 2014–20 budget, including €78.6 billion ($103.4 billion = €0.76 = $1) in funding for Horizon 2020, the EU’s primary research program. Horizon 2020 replaces the 7th Research Framework Programme and incorporates funding for the European Institute of Innovation and Technology and parts of the Competitiveness and Innovation […]

Third quarter revenues for IBO’s Lab Equipment/Consumables Sales Index grew 1.4%, 2.8% excluding currency, to $4,060 million. Operating profits for the Index rose 3.9% to $699 million. Based on continuing operations, operating margin expanded 40 basis points to 18.2% of sales. Kewaunee Scientific’s fiscal second quarter 2014 sales ending October 31 contracted 16.3% to $26.1 […]

Third quarter sales for the Life Science Index grew 3.2%, 5.5% excluding currency, to $3,366 million. Operating profit improved 2.7% to $675 million. Based on continuing operations, operating margin slipped 20 basis points to 21.3% of sales. Fiscal fourth quarter revenue for Becton Dickinson’s BD Biosciences segment advanced 10.0%, 11.6% excluding currency, to $300 million […]

Toulouse, France 12/10/13—Alpha MOS has confirmed to IBO that the company has filed for Chapter 11 protection in France. Describing the company’s plans following a court hearing, Alpha MOS President Jean Christophe Mifsud told IBO, “We have six months probation during which we are going to continue our focus on food safety and food quality, […]

R&D spending by US universities declined 3.3% in fiscal year 2012 (FY12) in constant 2005 dollars to $34.6 billion—the first decline in 38 years. Adjusted for inflation, federal government academic R&D spending fell 1.6% to $40,130 million. However, excluding the federal government, R&D spending by US universities rose 4.7% to $25,644 million adjusted for inflation. […]

Company Announcements Hitachi High-Technologies’ fiscal second quarter 2014 Science and Medical Systems (SMS) sales grew 7.5% to ¥37.1 billion ($375.2 million = ¥98.89= $1) due to the acquisition of SII NanoTechnology (see IBO 12/15/12) and currency. Sales of Electron Microscopes and Other Scientific Instruments climbed 8.3% and 47.7% to account for 21% and 18% of […]

The Dow Jones Industrial Average and S&P traded at record levels in November, crossing the 16,000 and 1,800 point levels, respectively, for the first time. US equity markets continued to be fueled by loose Federal Reserve monetary policies, but were also heightened by modest economic advances, including improving manufacturing and consumer spending data, as well […]

Despite continuing weakness in many government and industrial markets, major US publicly held analytical instrument and lab product firms generated revenue growth in the calendar year third quarter, as demand from China and applied markets remained strong. In addition, select life science markets, such as those related to sequencing, were healthy. Businesses reported little overall […]

R&D spending by two thousand of the world’s largest companies grew 6.2% in fiscal 2012 to more than €538.8 billion ($690.8 billion = €0.78 = $1), with 70% of the companies increasing R&D expenditures, according to the recently published The 2012 EU Industrial R&D Investment Scoreboard. This compares to 6.2% growth for these companies in […]